Search

everythinglearnresearchcommunity

for

Search:↓

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Baricitinib shows promise in treating severe hair loss.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

A new combination of tadalafil and finasteride improves drug performance and stability.

Fucoidan may help regrow hair and reduce inflammation in hair loss.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Errors found in identifying furosemide and finasteride polymorphs due to incomplete data.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Hydroxychloroquine is ineffective for treating frontal fibrosing alopecia with lupus erythematosus.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Clofazimine may be effective for treating ashy dermatosis.

Stopping leflunomide healed the woman's skin ulcers.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

FLCN helps control iron levels in cells.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Cinainu is effective and safe for treating children's alopecia areata.

Alfuzosin reduces short-term surgery need after catheter removal, but long-term benefits are unclear; combination therapy may help prevent urinary issues.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.